---
title: "Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder | CMND Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286102175.md"
description: "Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder | CMND Stock News"
datetime: "2026-05-12T04:45:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286102175.md)
  - [en](https://longbridge.com/en/news/286102175.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286102175.md)
---

# Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder | CMND Stock News

Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder | CMND Stock News

### Related Stocks

- [CMND.US](https://longbridge.com/en/quote/CMND.US.md)

## Related News & Research

- [Clearmind Medicine Announces 1-for-10 Reverse Stock Split; Stock Down](https://longbridge.com/en/news/286961923.md)
- [Clearmind Medicine CEO Dr. Adi Zuloff-Shani named Delegate to Federal Policy Summit on Psychedelic Medicine in Washington, D.C. | CMND Stock News](https://longbridge.com/en/news/286566409.md)
- [Clearmind Medicine Announces “Inside MEAI” Webinar Featuring New Insights from CMND-100 Psychedelic Clinical Trial | CMND Stock News](https://longbridge.com/en/news/285936790.md)
- [Here's How Much $100 Invested In BeOne Medicines 10 Years Ago Would Be Worth Today](https://longbridge.com/en/news/286947117.md)
- [Clearmind Medicine's CMND-100 Trial Clears Safety Review For Alcohol Use Disorder](https://longbridge.com/en/news/282928715.md)